ストックスクリーナーアプリを入手
177.32
0.60%
-1.07
前日終値:
$178.39
開ける：
$177.2
24時間の取引高:
432.92K
Relative Volume:
0.85
時価総額：
$5.26B
収益：
$755.59M
当期純損益:
$33.05M
株価収益率:
165.72
EPS:
1.07
ネットキャッシュフロー:
$38.20M
1週間 パフォーマンス:
-4.47%
1か月 パフォーマンス:
-4.20%
6か月 パフォーマンス:
-5.34%
1年 パフォーマンス:
-3.97%
1日の値動き範囲:
$173.38
$178.72
1週間の範囲:
$173.38
$185.37
52週間の値動き範囲:
$123.00
$257.40
Inspire Medical Systems Inc Stock (INSP) Company Profile
名前
Inspire Medical Systems Inc
セクター
電話
763-957-5037
住所
5500 WAYZATA BLVD, GOLDEN VALLEY
INSP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
177.32 | 5.26B | 755.59M | 33.05M | 38.20M | 1.07 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-05-08 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-04-19 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | 開始されました | Jefferies | Buy |
| 2024-01-02 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-13 | アップグレード | Goldman | Neutral → Buy |
| 2022-12-13 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-11-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-11-03 | アップグレード | Oppenheimer | Underperform → Perform |
| 2020-09-22 | 開始されました | JP Morgan | Overweight |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-06 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-07-15 | 開始されました | Goldman | Buy |
| 2020-06-18 | 繰り返されました | Piper Sandler | Overweight |
| 2020-05-18 | 開始されました | Lake Street | Buy |
| 2020-04-28 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | 開始されました | Piper Sandler | Overweight |
| 2020-01-28 | 開始されました | Oppenheimer | Underperform |
| 2020-01-27 | 開始されました | Oppenheimer | Underperform |
| 2019-11-06 | アップグレード | Berenberg | Sell → Hold |
| 2019-02-05 | 開始されました | Dougherty & Company | Buy |
| 2018-11-28 | 開始されました | Berenberg | Sell |
| 2018-10-29 | 開始されました | Leerink Partners | Outperform |
| 2018-05-29 | 開始されました | Guggenheim | Buy |
| 2018-05-29 | 開始されました | Stifel | Buy |
| 2018-05-29 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Inspire Medical Systems Inc (INSP) 最新ニュース
INVESTOR ALERT: Levi & Korsinsky Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 20, 2024INSP - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 20, 2024 – INSP - ACCESS Newswire
FINAL INSP DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Inspire Medical Systems, Inc. Investors of Last Few Hours to Join the Class Action Lawsuit! - ACCESS Newswire
Inspire Medical Systems: Will The Expansion of Inspira V Be A Game Changer? - Smartkarma
Inspire medical systems exec sells shares worth $4.69 million - Investing.com India
Inspire medical systems exec sells shares worth $4.69 million By Investing.com - Investing.com Nigeria
Inspire Medical Systems' SWOT analysis: stock poised for growth amid challenges - MSN
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical ... - The Bakersfield Californian
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder - GlobeNewswire
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts - MSN
Inspire medical systems CTO sells $99,395 in stock - MSN
FY2028 Earnings Forecast for INSP Issued By Leerink Partnrs - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat
John Rondoni Sells 583 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) Stock - MarketBeat
Wells Fargo & Company Issues Pessimistic Forecast for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat
Inspire Medical Systems (NYSE:INSP) Price Target Lowered to $248.00 at Robert W. Baird - MarketBeat
Leerink Partnrs Issues Positive Outlook for INSP Earnings - MarketBeat
Inspire medical systems CTO sells $99,395 in stock By Investing.com - Investing.com Australia
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat
WCM Investment Management LLC Takes $10.29 Million Position in Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat
Piper Sandler Cuts Inspire Medical Systems (NYSE:INSP) Price Target to $233.00 - MarketBeat
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88% - Nasdaq
Inspire Medical Systems, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Canada Finance
Truist Financial Has Lowered Expectations for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat
Inspire Medical's Earnings Surge in Q4 - MSN
Inspire Medical price target lowered to $235 from $250 at Truist - Yahoo Finance
Inspire Medical Systems targets $940M-$955M revenue in 2025 with Inspire V launch - MSN
Piper Sandler cuts Inspire Medical stock target to $233 - MSN
Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook - br.ADVFN.com
Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates - MSN
Inspire Medical discloses DOJ civil false claims investigation - Fierce Biotech
Inspire Medical reveals DOJ civil investigation - MedTech Dive
Truist cuts Inspire Medical stock target to $235, retains buy rating - MSN
Leerink lifts Inspire Medical stock target to $194, maintains rating - MSN
RBC maintains Outperform on Inspire Medical, $260 price target - MSN
Inspire Medical Systems (NYSE:INSP) Shares Gap Down on Analyst Downgrade - MarketBeat
Piper Sandler maintains overweight on Inspire Medical stock, $233 target - MSN
Morgan Stanley cuts Inspire Medical stock target to $220 - MSN
Truist Adjusts Price Target on Inspire Medical Systems to $235 From $250, Maintains Buy Rating - Marketscreener.com
Inspire V on Track for Full Launch in 2025 - Sleep Review
A Look At The Fair Value Of Inspire Medical Systems, Inc. (NYSE:INSP) - Yahoo Canada Finance
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2024 Earnings Call Transcript - Insider Monkey
Inspire Medical Systems: Balancing Strong Performance with Operational Challenges and Regulatory Risks - TipRanks
Inspire Medical Systems revenue grows 25% in Q4 2024 - Medical Buyer
Lecap Asset Management Ltd. Has $974,000 Stake in Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat
Janney Montgomery Scott LLC Buys 3,427 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat
Inspire Medical Systems Inc (INSP) Q4 2024 Earnings Call Highlig - GuruFocus.com
Inspire Medical Systems Inc (INSP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Inspire Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Inspire Medical Systems Inc (INSP) 財務データ
収益
当期純利益
現金流量
EPS
1.16%
0.10%
大文字化:
|
ボリューム (24 時間):